Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11461735 | 1.00 | GAA (0.68) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5360093 | 1.00 | GAA (0.68) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL189919 | 0.84 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL12131284 | 0.84 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL6060474 | 0.84 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL3892921 | 0.84 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL189920 | 0.84 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL4353902 | 0.83 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL12997589 | 0.83 | GAA (0.65) | GAACYP2C19SMN1; SMN2NPC1RAB9A | |
| SCHEMBL28249859 | 0.82 | CYP2C19 (0.52) | GAACYP2C19SMN1; SMN2CES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117185954-A | Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof | 江西天宇化工有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-112851546-B | Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof | 江西天宇化工有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-112851546-A | Preparation method of (E) -2-methyl-alpha-methoxyimino methyl phenylacetate and intermediate thereof | 江西天宇化工有限公司 | 2021-05-28 | — | — | CN | claimed |
| EP-0628540-B1 | 2-Oximino-2-phenyl-acetamides | BAYER AG (DE) | 1999-01-20 | — | — | EP | claimed |
| EP-4591121-A1 | USE OF A METAL AND/OR METALLOID-COMPRISING KETOACIDOXIMATE AND/OR A METAL-COMPOUND-COMPRISING KETOACIDOXIMATE AS A PATTERNING AGENT | PAUL SCHERRER INSTITUT (CH) | 2025-07-30 | — | — | EP | disclosed |
| CN-220835569-U | Device for continuously synthesizing (E) -2-methyl-alpha-oxyiminophenylacetic acid | 湖北省祥珈科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024061550-A1 | USE OF A METAL AND/OR METALLOID-COMPRISING KETOACIDOXIMATE AND/OR A METAL-COMPOUND-COMPRISING KETOACIDOXIMATE AS A PATTERNING AGENT | PAUL SCHERRER INSTITUT (CH) | 2024-03-28 | — | — | WO | disclosed |
| CN-117185954-A | Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof | 江西天宇化工有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-112851546-B | Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof | 江西天宇化工有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-112851546-A | Preparation method of (E) -2-methyl-alpha-methoxyimino methyl phenylacetate and intermediate thereof | 江西天宇化工有限公司 | 2021-05-28 | — | — | CN | disclosed |
| US-7501513-B2 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2009-03-10 | — | — | US | disclosed |
| EP-1658081-B1 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA IP NV (BE) | 2007-10-24 | — | — | EP | disclosed |
| EP-0149242-A2 | 1-(2-Hydroxyaryl)-alcan-1-one oxime, preparation and pharmaceutical use | CHEMISCHE UND PHARMAZEUTISCHE FABRIKEN FAHLBERG-LIST GmbH (DE) | 1985-07-24 | — | — | EP | disclosed |
| US-4334087-A | FROM AN OXIMINOHALIDE | ZOECON CORPORATION (US) | 1982-06-08 | — | — | US | disclosed |
| US-4278670-A | TREATING BACTERIAL INFECTIONS | SMITHKLINE CORPORATION (US) | 1981-07-14 | — | — | US | disclosed |
| US-4208517-A | Caphalosporin compounds having at position-7 an α-etherified hydroxyiminoarylacetamido group | GLAXO OPERATIONS UK LIMITED (GB) | 1980-06-17 | — | — | US | disclosed |
| US-4203896-A | WITH MERCURIC ACETATE AND ACETIC ACID, ACIDIC HYDROLYSIS OF N-PROPENYL GROUP | ELI LILLY AND COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4144232-A | Substituted azetidin-2-one antibiotics | ELI LILLY AND COMPANY (US) | 1979-03-13 | — | — | US | disclosed |
| US-4007174-A | Cephalosporin compounds | GLAXO LABORATORIES LIMITED (EN) | 1977-02-08 | — | — | US | disclosed |
| US-3969401-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC | WILLIAM H. RORER, INC. (US) | 1976-07-13 | — | — | US | disclosed |